Literature DB >> 28533241

Arr-cb Is a Rifampin Resistance Determinant Found Active or Cryptic in Clostridium bolteae Strains.

Jean-Christophe Marvaud1, Thierry Lambert2.   

Abstract

Clostridiumbolteae, which belongs to the Clostridium clostridioforme complex, is a member of the human gut microbiota. Recent analysis of seven genomes of Cbolteae revealed the presence of an arr-like gene. Among these strains, only 90A7 was found to be resistant to rifampin in the absence of alteration of RpoB. Cloning of arr-cb from 90A7 in Escherichia coli combined with directed mutagenesis demonstrated that Arr-cb was functional but that a Q127→R variant present in 90A9 and 90B3 was inactive. Quantitative reverse transcription-PCR analysis indicated that arr-cb was silent in the four remaining strains because of defective transcription. Thus, two independent mechanisms can make the probably intrinsic arr-cb gene of Cbolteae cryptic.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Clostridium bolteae; antibiotic resistance; rifampin ADP-ribosyltransferase

Mesh:

Substances:

Year:  2017        PMID: 28533241      PMCID: PMC5527633          DOI: 10.1128/AAC.00301-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  An efficient one-step site-directed and site-saturation mutagenesis protocol.

Authors:  Lei Zheng; Ulrich Baumann; Jean-Louis Reymond
Journal:  Nucleic Acids Res       Date:  2004-08-10       Impact factor: 16.971

Review 2.  Antibiotics for preventing meningococcal infections.

Authors:  Anca Zalmanovici Trestioreanu; Abigail Fraser; Anat Gafter-Gvili; Mical Paul; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

3.  Inactivation of rifampin by Nocardia brasiliensis.

Authors:  K Yazawa; Y Mikami; A Maeda; M Akao; N Morisaki; S Iwasaki
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

4.  Escherichia coli promoter sequences predict in vitro RNA polymerase selectivity.

Authors:  M E Mulligan; D K Hawley; R Entriken; W R McClure
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

Review 5.  Resistance to rifampicin: a review.

Authors:  Beth P Goldstein
Journal:  J Antibiot (Tokyo)       Date:  2014-08-13       Impact factor: 2.649

Review 6.  Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns.

Authors:  Audrey Tupin; Maxime Gualtieri; Françoise Roquet-Banères; Zakia Morichaud; Konstantin Brodolin; Jean-Paul Leonetti
Journal:  Int J Antimicrob Agents       Date:  2010-02-24       Impact factor: 5.283

7.  Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr.

Authors:  Jennifer Baysarowich; Kalinka Koteva; Donald W Hughes; Linda Ejim; Emma Griffiths; Kun Zhang; Murray Junop; Gerard D Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-18       Impact factor: 11.205

8.  The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations.

Authors:  M D Collins; P A Lawson; A Willems; J J Cordoba; J Fernandez-Garayzabal; P Garcia; J Cai; H Hippe; J A Farrow
Journal:  Int J Syst Bacteriol       Date:  1994-10

9.  Comparative genomics of Clostridium bolteae and Clostridium clostridioforme reveals species-specific genomic properties and numerous putative antibiotic resistance determinants.

Authors:  Pierre Dehoux; Jean Christophe Marvaud; Amr Abouelleil; Ashlee M Earl; Thierry Lambert; Catherine Dauga
Journal:  BMC Genomics       Date:  2016-10-21       Impact factor: 3.969

Review 10.  The human gut resistome.

Authors:  Willem van Schaik
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

View more
  1 in total

1.  Genomic epidemiology of rifampicin ADP-ribosyltransferase (Arr) in the Bacteria domain.

Authors:  Sergio Morgado; Érica Fonseca; Ana Carolina Vicente
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.